Information Provided By:
Fly News Breaks for November 12, 2018
ZTS
Nov 12, 2018 | 09:23 EDT
BMO Capital analyst Alex Arfaei raised his price target on Zoetis to $93 after its Q3 earnings beat and raised FY18 guidance. The analyst acknowledges that the company's "commercial and R&D execution have been excellent", leading to its premium valuation. Arfaei keeps his Market Perform on Zoetis however, noting that in spite of its performance amid the reasonably high expectations, the company's insufficient pipeline visibility and premium valuation warrant a neutral stance.